| NDC Code | 0555-0589-01 |
|---|
| Package Description | 30 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (0555-0589-01) |
|---|
| Product NDC | 0555-0589 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Didanosine |
|---|
| Non-Proprietary Name | Didanosine |
|---|
| Dosage Form | CAPSULE, DELAYED RELEASE PELLETS |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20041215 |
|---|
| End Marketing Date | 20190331 |
|---|
| Marketing Category Name | ANDA |
|---|
| Application Number | ANDA077167 |
|---|
| Manufacturer | Teva Pharmaceuticals USA, Inc. |
|---|
| Substance Name | DIDANOSINE |
|---|
| Strength | 250 |
|---|
| Strength Unit | mg/1 |
|---|
| Pharmacy Classes | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
|---|